Effects of a new 5α reductase inhibitor (epristeride) on human prostate cell culturesROBINSON, E. J; COLLINS, A. T; ROBSON, C. N et al.The Prostate. 1997, Vol 32, Num 4, pp 259-265, issn 0270-4137Article

Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitorZHIYIYAO; YINGJUN XU; MINMIN ZHANG et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 1, pp 475-478, issn 0960-894X, 4 p.Article

Reversible long-term toxicity of epristeride in beagle dogsSUN, Z.-Y; JIE FENG; QI, X.-D et al.Toxicology and applied pharmacology. 1999, Vol 154, Num 2, pp 145-152, issn 0041-008XArticle

The mechanism of epristeride against benign prostatic hyperplasiaSUN, Z.-Y; WU, H.-Y; WANG, M.-Y et al.European journal of pharmacology. 1999, Vol 371, Num 2-3, pp 227-233, issn 0014-2999Article

A fluorescence spectroscopic study of the interaction between epristeride and bovin serum albumine and its analytical applicationAIQIN GONG; XIASHI ZHU; YANYAN HU et al.Talanta (Oxford). 2007, Vol 73, Num 4, pp 668-673, issn 0039-9140, 6 p.Article

Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5α-reductase isoform 2LEVY, M. A; BRANDT, M; SHEEDY, K. M et al.Journal of steroid biochemistry and molecular biology. 1994, Vol 48, Num 2-3, pp 197-206, issn 0960-0760Article